9 Immunohistochemical detection of cyclooxygenase-2 in pancreatic ductai adenocarcinomas and neuroendocrine tumors

Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas

Volumn 3, Issue , 2005, Pages 357-361

  Ohike, nobuyuki ^a   Kloppel, Gunter ^a   Morohoshi, Toshio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547656065     PISSN: 18745784     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5784(05)80041-8     Document Type: Chapter

References (33)

1. Aoki T., Nagakawa Y., Tsuchida A., Kasuya K., Kitamura K., Inoue K., Ozawa T., Koyanagi Y., and Itoi T. Expression of cyclooxygenase-2 and vascular endothelialgrowth factor in pancreatic tumors. Oncol. Rep. 9 (2002) 761-765
2. Cornetta A.J., Russell J.R., Cunnane M., Keane W.M., and Rothstein J.L. Cyclooxygenase-2 expression in humanthyroid carcinoma and Hashimoto's thyroiditis. Laryngoscope 112 (2002) 238-242
3. Ding X.Z., Tong W.G., and Adrian T.E. Blockade ofcyclooxygenase-2 inhibits proliferation and induces apoptosisin human pancreatic cancer cells. Anticancer Res. 20 (2000) 2625-2631
4. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation ofcyclooxygenase 2 gene expression in human colorectal adeno-mas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
5. Fujiwaki R., Iida K., Kanasaki H., Ozaki T., Hata K., and Miyazaki K. Cyclooxygenase-2 expression in endome-trial cancer: Correlation with microvessel count and expressionof vascular endothelial growth factor and thymidine phosp. Hum. Pathol. 33 (2002) 213-219
6. Hao X., Bishop A.E., Wallace M., Wang H., Willcocks T.C., Maclouf J., Polak J.M., Knight S., and Talbot I.C. Earlyexpression of cyclo-oxygenase-2 during sporadic colorectalcarcinogenesis. J. Pathol. 187 (1999) 295-301
7. Kang R.Y., Freire-Moar J., Sigal E., and Chu C.Q. Expression of cyclooxygenase-2 in human and an animal modelof rheumatoid arthritis. Br. J. Rheumatol. 35 (1996) 711-718
8. Kondo M., Yamamoto H., Nagano H., Okami J., Ito Y., Shimizu J., Eguchi H., Miyamoto A., Dono K., Umeshita K., Matsuura N., Wakasa K., Nakamori S., Sakon M., and Monden M. Increased expression of COX-2 in nontumor liver tissue isassociated with shorter disease-free survival in patients withhepatocellular carcinoma. Clin. Cancer Res. 5 (1999) 4005-4012
9. Koshiba T., Hosotani R., Miyamoto Y., Wada M., Lee J.U., Fujimoto K., Tsuji S., Nakajima S., Doi R., and Imamura M. Immunohistochemical analysis of cyclooxygenase-2expression in pancreatic tumors. Int. J. Pancreatol. 26 (1999) 69-76
10. Lim H.Y., Joo H.J., Choi J.H., Yi J.W., Yang M.S., Cho D.Y., Kim H.S., Nam D.K., Lee K.B., and Kim H.C. Increased expression of cyclooxygenase-2 protein in humangastric carcinoma. Clin. Cancer Res. 6 (2000) 519-525
11. Luo C., Kallajoki M., Gross R., Mulari M., Teros T., Ylinen L., Makinen M., Laine J., and Simell O. Cellular distribu-tion and contribution of cyclooxygenase (COX)-2 to diabetoge-nesis in NOD mouse. Cell Tissue Res. 370 (2002) 169-175
12. Liittges J., Galehdari H., Brocker V., Schwarte-Waldhoff I., Henne-Bruns D., Kloppel G., Schmiegel W., and Hahn S.A. Allelic loss is often the first hit in the biallelic inactiva-tion of the p53 and DPC4 genes during pancreatic carcinogen-esis. Am. J. Pathol. 155 (2001) 1677-1683
13. Maitra A., Ashfaq R., Gunn C.R., Rahman A., Yeo C.J., Sohn T.A., Cameron J.L., Hruban R.H., and Wilentz R.E. Cyclooxygenase 2 expression in pancreatic adenocarcinomaand pancreatic intraepithelial neoplasia: An immunohistochem-ical analysis with automated cellular ima. Am. J. Clin.Pathol. 118 (2002) 194-201
14. Merati K., said Siadaty M., Andea A., Sarkar F., Ben-Josef E., Mohammad R., Philip P., Shields A.F., Vaitkevicius V., Grignon D.J., and Adsay N.V. Expression of inflamma-tory modulator COX-2 in pancreatic ductal adenocarcinomaand its relationship to pathologic and clinical parameters. Am.J. Clin. Oncol. 24 (2001) 447-452
15. Molina M.A., Sitja-Arnau M., Lemoine M.G., Frazier M.L., and Sinicrope F.A. Increased cyclooxygenase-2 expressionin human pancreatic carcinomas and cell lines: Growth inhibi-tion by nonsteroidal anti-inflammatory drugs. Cancer Res. 59 (1999) 4356-4362
16. Nathan C.A., Leskov I.L., Lin M., Abreo F.W., Shi R., Hartman G.H., and Glass J. COX-2 expression indysplasia of the head and neck: Correlation with elF4E. Cancer 92 (2001) 1888-1895
17. Niijima M., Yamaguchi T., Ishihara T., Hara T., Kato K., Kondo F., and Saisho H. Immunohistochemical analysisand in situ hybridization of cyclooxygenase-2 expression inintraductal papillary-mucinous tumors of the pancreas. Cancer 94 (2002) 1565-1573
18. Ohike N., and Morohoshi T. Immunohistochemical analysisof cyclooxygenase (COX)-2 expression in pancreatic endocrinetumors: Association with tumor progression and proliferation. Pathol. Int. 51 (2001) 770-777
19. Okami J., Nakamori S., Yamamoto H., Sakon M., Tsujie M., Hayashi N., Nagano H., Dono K., Umeshita K., Ishikawa O., Ohigashi H., and Monden M. An immunohistochemicalstudy of cyclooxygenase (COX)-2 expression in endocrinetumors of the pancreas. J. Exp. Clin. Cancer Res. 27 (2002) 569-576
20. Okami J., Yamamoto H., Fujiwara Y., Tsujie M., Kondo M., Noura S., Oshima S., Nagano H., Dono K., Umeshita K., Ishikawa O., Sakon M., Matsuura N., Nakamori S., and Monden M. Overexpression of cyclooxygenase-2 incarcinoma of the pancreas. Clin. Cancer Res. 5 (1999) 2018-2024
21. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., and Taketo M.M. Suppression of intestinal polyposis in Ape delta716 knockoutmice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (1996) 803-809
22. Sabattini E., Bisgaard K., Ascani S., Poggi S., Piccioli M., Ceccarelli C., Pieri F., Fraternali-Orcioni G., and Pileri S.A. The EnVision-++ system: A new immunohistochemicalmethod for diagnostics and research: Critical comparison withthe APAAP, ChemMate, GSA, LABC, and SABC techniq. J. Clin. Pathol. 51 (1998) 506-511
23. Salmenkivi K., Haglund C., Ristimaki A., Arola J., and Heikkila P. Increased expression of cyclooxygenase-2 inmalignant pheochromocytomas. J. Clin. Endocrinol. Metab. 86 (2001) 5615-5619
24. Sawaoka H., Kawano S., Tsuji S., Tsuji M., Sun W., Gunawan E.S., and Hori M. Helicobacter pylori infection inducescyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot. Essent. Fatty Acids 59 (1998) 313-316
25. Schlosser W., Schlosser S., Ramadani M., Gansauge F., Gansauge S., and Beger H.G. Cyclooxygenase-2 isoverexpressed in chronic pancreatitis. Pancreas 25 (2002) 26-30
26. Shamma A., Yamamoto H., Doki Y., Okami J., Kondo M., Fujiwara Y., Yano M., Inoue M., Matsuura N., Shiozaki H., and Monden M. Up-regulation of cyclooxygenase-2 insquamous carcinogenesis of the esophagus. Clin. Cancer Res. 6 (2000) 1229-1238
27. Singer II., Kawka D.W., Schloemann S., Tessner T., Riehl T., and Stenson W.F. Cyclooxygenase 2 is induced incolonic epithelial cells in inflammatory bowel disease. Gastroenterology 775 (1998) 297-306
28. Solcia E., Kloppel G., and Sobin L.H. Endocrine tumoursof the pancreas. In: Solcia E., Kloppel G., and Sobin L.H. (Eds). Histological Typing of Endocrine Tumours: InternationalHistological Classification of Tumours (2000), World Health Organization, Heidelberg, Germany 56-60
29. Takahashi M., Furukawa F., Toyoda K., Sato H., Hasegawa R., Imaida K., and Hayashi Y. Effects of variousprostaglandin synthesis inhibitors on pancreatic carcinogenesisin hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 11 (1990) 393-395
30. 3rd. Tucker O.N., Dannenberg A.J., Yang E.K., Zhang R., Teng L., Daly J.M., Soslow R.A., Masferrer J.L., Woerner B.M., Koki A.T., and Fahey T.J. Cyclooxygenase-2expression is up-regulated in human pancreatic cancer. Cancer Res. 59 (1999) 987-990
31. Uotila P., Valve E., Martikainen P., Nevalainen M., Nurmi M., and Harkonen P. Increased expression of cyclooxygenase-2and nitric oxide synthase-2 in human prostate cancer. Urol. Res. 29 (2001) 23-28
32. Wilson K.T., Fu S., Ramanujam K.S., and Meltzer S.J. Increased expression of inducible nitric oxide synthase andcyclooxygenase-2 in Barrett's esophagus and associated adeno-carcinomas. Cancer Res. 58 (1998) 2929-2934
33. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., and Ristimaki A. Expression of cyclooxygenase-2 inhuman lung carcinoma. Cancer Res. 58 (1998) 4997-5001